DYSIS Medical is a medical technology commercialization company that provides clinicians with a high-resolution digital Smart Colposcope to help with the identification of the most relevant biopsy sites when cancerous and pre-cancerous cervical cancer lesions are suspected.
Biom’Up develops and commercializes hemostatic products based on patented biopolymer designed to simplify surgeons’ practices for open surgical procedures in numerous specialties such as cardiac, general, orthopedic, and laparoscopic surgeries.
Amplyx Pharmaceuticals develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems.
scPharmaceuticals provides subcutaneous administration of therapies that have previously been limited to intravenous, or IV, delivery reducing overall healthcare costs and advances the quality and convenience of care.
Aura Biosciences is a biopharmaceutical company aiming to transform the treatment of early-stage tumours to prevent metastasis and improve outcomes for patients with cancer.
